Literature DB >> 33287435

Depicting HIV-1 Transcriptional Mechanisms: A Summary of What We Know.

Antoine Dutilleul1, Anthony Rodari1, Carine Van Lint1.   

Abstract

Despite the introduction of combinatory antiretroviral therapy (cART), HIV-1 infection cannot be cured and is still one of the major health issues worldwide. Indeed, as soon as cART is interrupted, a rapid rebound of viremia is observed. The establishment of viral latency and the persistence of the virus in cellular reservoirs constitute the main barrier to HIV eradication. For this reason, new therapeutic approaches have emerged to purge or restrain the HIV-1 reservoirs in order to cure infected patients. However, the viral latency is a multifactorial process that depends on various cellular mechanisms. Since these new therapies mainly target viral transcription, their development requires a detailed and precise understanding of the regulatory mechanism underlying HIV-1 transcription. In this review, we discuss the complex molecular transcriptional network regulating HIV-1 gene expression by focusing on the involvement of host cell factors that could be used as potential drug targets to design new therapeutic strategies and, to a larger extent, to reach an HIV-1 functional cure.

Entities:  

Keywords:  HIV-1; HIV-1 latency; HIV-1 transcriptional regulation

Year:  2020        PMID: 33287435     DOI: 10.3390/v12121385

Source DB:  PubMed          Journal:  Viruses        ISSN: 1999-4915            Impact factor:   5.048


  5 in total

Review 1.  Defective HIV-1 genomes and their potential impact on HIV pathogenesis.

Authors:  Jeffrey Kuniholm; Carolyn Coote; Andrew J Henderson
Journal:  Retrovirology       Date:  2022-06-28       Impact factor: 3.768

Review 2.  A "Drug-Dependent" Immune System Can Compromise Protection against Infection: The Relationships between Psychostimulants and HIV.

Authors:  María Amparo Assis; Pedro Gabriel Carranza; Emilio Ambrosio
Journal:  Viruses       Date:  2021-04-21       Impact factor: 5.048

Review 3.  Infectious RNA: Human Immunodeficiency Virus (HIV) Biology, Therapeutic Intervention, and the Quest for a Vaccine.

Authors:  Yasemin van Heuvel; Stefanie Schatz; Jamila Franca Rosengarten; Jörn Stitz
Journal:  Toxins (Basel)       Date:  2022-02-14       Impact factor: 4.546

4.  Combined noncanonical NF-κB agonism and targeted BET bromodomain inhibition reverse HIV latency ex vivo.

Authors:  Shane D Falcinelli; Jackson J Peterson; Anne-Marie W Turner; David Irlbeck; Jenna Read; Samuel Lm Raines; Katherine S James; Cameron Sutton; Anthony Sanchez; Ann Emery; Gavin Sampey; Robert Ferris; Brigitte Allard; Simon Ghofrani; Jennifer L Kirchherr; Caroline Baker; JoAnn D Kuruc; Cynthia L Gay; Lindsey I James; Guoxin Wu; Paul Zuck; Inmaculada Rioja; Rebecca C Furze; Rab K Prinjha; Bonnie J Howell; Ronald Swanstrom; Edward P Browne; Brian D Strahl; Richard M Dunham; Nancie M Archin; David M Margolis
Journal:  J Clin Invest       Date:  2022-04-15       Impact factor: 19.456

Review 5.  Forging a Functional Cure for HIV: Transcription Regulators and Inhibitors.

Authors:  Sonia Mediouni; Shuang Lyu; Susan M Schader; Susana T Valente
Journal:  Viruses       Date:  2022-09-07       Impact factor: 5.818

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.